DocGo Inc. Payments of Stock Issuance Costs
DocGo Inc. (DCGO) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-02-27
- DocGo Inc. payments of stock issuance costs for the quarter ending 2023-12-31 was $0.00.
- DocGo Inc. payments of stock issuance costs for the quarter ending 2023-09-30 was $0.00.
- DocGo Inc. payments of stock issuance costs for the quarter ending 2022-12-31 was $0.00.
- DocGo Inc. payments of stock issuance costs for the quarter ending 2022-09-30 was $0.00.
- DocGo Inc. payments of stock issuance costs for fiscal 2024 was $0.00.
- DocGo Inc. payments of stock issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- DocGo Inc. payments of stock issuance costs for fiscal 2022 was $19.57K.
- DocGo Inc. payments of stock issuance costs for fiscal 2021 was $0.00.
| Period end | Payments of Stock Issuance Costs 2 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 5 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $0.00 10-Q · filed 2023-11-06 | |||||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | ||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $19.57K 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-06 | $19.57K 10-Q · filed 2023-11-06 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $19.57K 10-Q · filed 2023-08-08 | |||||
| 2022-03-31 | $19.57K 10-Q · filed 2023-05-09 | ||||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | $19.96M 10-K · filed 2022-03-15 | |||||
| 2020-12-31 | $6.79M 10-K/A · filed 2021-11-24 | ||||||
| 2020-09-30 | $67.57K 10-Q/A · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |